Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

Summary

The primary objective of this study is to investigate the effectiveness of intralesional (IL) PV-10 for locoregional treatment of metastatic melanoma. This study will also include assessment of response in untreated bystander lesions following intralesional injection of PV-10 into targeted lesions. Additional objectives are to determine the safety profile of PV-10 following intralesional injection, and assess the pharmacokinetic profile of PV-10 in the bloodstream following intralesional injection.

Timeline

Start

2007-09

Primary completion

2010-05

Completion

2012-06

Drugs

Indications